{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:03:07Z","timestamp":1765231387411,"version":"3.38.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.revmed.2024.11.001","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T21:02:48Z","timestamp":1731704568000},"page":"164-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human papillomavirus et lupus syst\u00e9mique\u00a0: une revue syst\u00e9matique"],"prefix":"10.1016","volume":"46","author":[{"given":"Tiphaine","family":"Goulenok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Sacr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2024.11.001_bib0435","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"Zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"year":"2005","series-title":"Cervix cancer screening: IARC Working Group on the evaluation on cancer-preventive strategies which met in Lyon, France, 20\u201327\u00a0April 2004","key":"10.1016\/j.revmed.2024.11.001_bib0440"},{"year":"2013","series-title":"Niveaux de preuves et gradation des recommandations de bonne pratique","author":"Haute Autorit\u00e9 de sant\u00e9","key":"10.1016\/j.revmed.2024.11.001_bib0445"},{"key":"10.1016\/j.revmed.2024.11.001_bib0450","first-page":"101","article-title":"High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse)","volume":"10","author":"Kjaer","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.revmed.2024.11.001_bib0455","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1093\/cid\/ciaa1050","article-title":"Importance of lifetime sexual history on the prevalence of genital Human Papillomavirus (HPV) among unvaccinated adults in the national health and nutrition examination surveys: implications for adult HPV vaccination","volume":"72","author":"Rositch","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.revmed.2024.11.001_bib0460","doi-asserted-by":"crossref","first-page":"e2537","DOI":"10.1002\/rmv.2537","article-title":"Human papillomavirus infection: epidemiology, biology, host interactions, cancer development, prevention, and therapeutics","volume":"34","author":"Wolf","year":"2024","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.revmed.2024.11.001_bib0465","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1473-3099(09)70108-2","article-title":"Clinician's guide to human papillomavirus immunology: knowns and unknowns","volume":"9","author":"Einstein","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.revmed.2024.11.001_bib0470","first-page":"82","article-title":"Prise en charge des l\u00e9sions cervicales HPV induites chez les patientes immunod\u00e9prim\u00e9es\u00a0\u2013\u00a0revue de la litt\u00e9rature","volume":"50","author":"Egloff","year":"2022","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"10.1016\/j.revmed.2024.11.001_bib0475","unstructured":"Cervical Cancer Elimination Initiative. https:\/\/www.who.int\/initiatives\/cervical-cancer-elimination-initiative. (accessed March 19, 2024)."},{"key":"10.1016\/j.revmed.2024.11.001_bib0480","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"De Martel","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.revmed.2024.11.001_bib0485","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019\u00a0update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2024.11.001_bib0490","doi-asserted-by":"crossref","first-page":"e001041","DOI":"10.1136\/rmdopen-2019-001041","volume":"5","author":"Furer","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.revmed.2024.11.001_bib0495","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.22667","article-title":"High risk of human papillomavirus type 16\u00a0infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients","volume":"57","author":"Nath","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2024.11.001_bib0500","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1002\/art.20616","article-title":"Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection","volume":"50","author":"Tam","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2024.11.001_bib0505","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3899\/jrheum.090644","article-title":"Natural history of cervical papilloma virus infection in systemic lupus erythematosus\u00a0\u2013\u00a0a prospective cohort study","volume":"37","author":"Tam","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2024.11.001_bib0510","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3346\/jkms.2010.25.10.1431","article-title":"Prevalence of Human Papilloma virus infections and cervical cytological abnormalities among Korean women with systemic lupus erythematosus","volume":"25","author":"Lee","year":"2010","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.revmed.2024.11.001_bib0515","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/0961203310372952","article-title":"Are women with lupus at higher risk of HPV infection?","volume":"19","author":"Klumb","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2024.11.001_bib0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/751853","article-title":"Predisposition to cervical atypia in systemic lupus erythematosus: a clinical and cytopathological study","volume":"2015","author":"Al-Sherbeni","year":"2015","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.revmed.2024.11.001_bib0525","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00296-012-2426-0","article-title":"Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus","volume":"33","author":"Lyrio","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.revmed.2024.11.001_bib0530","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/0961203314559628","article-title":"Lack of association between serum 25-hydroxyvitamin D levels and cervical human papillomavirus infection in systemic lupus erythematosus","volume":"24","author":"Garc\u00eda-Carrasco","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2024.11.001_bib0535","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0961203311425517","article-title":"Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis","volume":"21","author":"Rojo-Contreras","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2024.11.001_bib0540","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1177\/0961203318773176","article-title":"Factors of the epidemiological triad that influence the persistence of human papilloma virus infection in women with systemic lupus erythematosus","volume":"27","author":"M\u00e9ndez-Mart\u00ednez","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2024.11.001_bib0545","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejim.2023.07.014","article-title":"Risk factors for high-risk human papillomavirus cervical infection and clearance in patients with systemic lupus erythematosus","volume":"116","author":"Goulenok","year":"2023","journal-title":"Eur J Int Med"},{"key":"10.1016\/j.revmed.2024.11.001_bib0550","doi-asserted-by":"crossref","first-page":"e0234813","DOI":"10.1371\/journal.pone.0234813","article-title":"Increased risk of cervical dysplasia in females with autoimmune conditions\u00a0\u2013\u00a0results from an Australia database linkage study","volume":"15","author":"Foster","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.revmed.2024.11.001_bib0555","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1016\/j.vaccine.2013.07.026","article-title":"Comprehensive control of Human Papillomavirus infections and related diseases","volume":"31","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.revmed.2024.11.001_bib0560","series-title":"Human papillomavirus and cervical cancer","first-page":"370","author":"Schiman","year":"2007"},{"key":"10.1016\/j.revmed.2024.11.001_bib0565","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.6061\/clinics\/2013(12)01","article-title":"The impact of glucocorticoids and anti-cd20\u00a0therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus","volume":"68","author":"Mendoza-Pinto","year":"2013","journal-title":"Clinics"},{"key":"10.1016\/j.revmed.2024.11.001_bib0570","doi-asserted-by":"crossref","first-page":"v26","DOI":"10.1093\/rheumatology\/kex523","article-title":"Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention","volume":"57","author":"Kim","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2024.11.001_bib0575","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1177\/0961203316686708","article-title":"Incidence of cervical human papillomavirus infection in systemic lupus erythematosus women","volume":"26","author":"Mendoza-Pinto","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2024.11.001_bib0580","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.autrev.2014.03.001","article-title":"Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: a meta-analysis of the literature","volume":"13","author":"Zard","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2024.11.001_bib0585","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1002\/art.30483","article-title":"High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term follow-up study in a Danish cohort","volume":"63","author":"Dreyer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2024.11.001_bib0590","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cac2.12283","article-title":"The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China","volume":"42","author":"Zhou","year":"2022","journal-title":"Cancer Commun"},{"key":"10.1016\/j.revmed.2024.11.001_bib0595","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/acr.24425","article-title":"Cancer risk in a large inception systemic lupus erythematosus cohort: effects of demographic characteristics, smoking, and medications","volume":"73","author":"Bernatsky","year":"2021","journal-title":"Arthritis Care Res"},{"issue":"9","key":"10.1016\/j.revmed.2024.11.001_bib0600","first-page":"1763","article-title":"Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide","volume":"31","author":"Ognenovski","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2024.11.001_bib0605","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/0961203316672928","article-title":"Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs","volume":"26","author":"Feldman","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2024.11.001_bib0610","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.33185","article-title":"A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale","volume":"148","author":"Clifford","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.revmed.2024.11.001_bib0615","doi-asserted-by":"crossref","first-page":"e0243150","DOI":"10.1371\/journal.pone.0243150","article-title":"Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis","volume":"16","author":"Johnson","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.revmed.2024.11.001_bib0620","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.berh.2008.12.007","article-title":"Malignancy in systemic lupus erythematosus: what have we learned?","volume":"23","author":"Bernatsky","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.revmed.2024.11.001_bib0625","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/BOR.0000000000000202","article-title":"Malignancies in systemic lupus erythematosus: a 2015\u00a0update","volume":"27","author":"Goobie","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.revmed.2024.11.001_bib0630","doi-asserted-by":"crossref","first-page":"e0122964","DOI":"10.1371\/journal.pone.0122964","article-title":"Systemic lupus erythematous and malignancy risk: a meta-analysis","volume":"10","author":"Cao","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.revmed.2024.11.001_bib0635","doi-asserted-by":"crossref","first-page":"e072249","DOI":"10.1136\/bmjopen-2023-072249","article-title":"Associations between immune-mediated diseases (IMDs) and the risk of HPV-associated diseases: a UK Biobank cohort analysis","volume":"13","author":"Feng","year":"2023","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.revmed.2024.11.001_bib0640","first-page":"CD009069","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","volume":"5","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2024.11.001_bib0645","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMcp2108502","article-title":"Human Papillomavirus vaccination","volume":"388","author":"Markowitz","year":"2023","journal-title":"N Engl J Med"},{"year":"2019","series-title":"Recommandations sur l\u2019\u00e9largissement de la vaccination contre les papillomavirus aux gar\u00e7ons","key":"10.1016\/j.revmed.2024.11.001_bib0650"},{"key":"10.1016\/j.revmed.2024.11.001_bib0655","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1136\/annrheumdis-2017-212789","article-title":"Impaired long-term immune protection following pneumococcal 13-valent\/23-valent polysaccharide vaccine in systemic lupus erythematosus (SLE)","volume":"77","author":"Sacre","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2024.11.001_bib0660","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/annrheumdis-2022-222498","article-title":"Severely impaired humoral response against SARS-CoV-2\u00a0variants of concern following two doses of BNT162b2\u00a0vaccine in patients with systemic lupus erythematosus (SLE)","volume":"81","author":"Mageau","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2024.11.001_bib0665","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-11-29","article-title":"Safety and immunogenicity of the quadrivalent HPV vaccine in female systemic lupus erythematosus patients aged 12\u00a0to 26\u00a0years","volume":"11","author":"Soybilgic","year":"2013","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.revmed.2024.11.001_bib0670","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.vaccine.2017.04.001","article-title":"The safety and immunogenicity of Quadrivalent HPV (qHPV) vaccine in systemic lupus erythematosus","volume":"35","author":"Dhar","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.revmed.2024.11.001_bib0675","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.vaccine.2018.04.056","article-title":"Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus","volume":"36","author":"Mok","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.revmed.2024.11.001_bib0680","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/annrheumdis-2012-201393","article-title":"Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case\u2013control study","volume":"72","author":"Mok","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2024.11.001_bib0685","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3899\/jrheum.130246","article-title":"Immunogenicity of the bivalent human papillomavirus vaccine in adolescents with juvenile systemic lupus erythematosus or juvenile dermatomyositis","volume":"40","author":"Heijstek","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2024.11.001_bib0690","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.revmed.2024.11.001_bib0695","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2017.01.005","article-title":"Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: six years of case-referent surveillance","volume":"79","author":"Grimaldi-Bensouda","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2024.11.001_bib0700","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/joim.12535","article-title":"Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study","volume":"280","author":"Gr\u00f6nlund","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.revmed.2024.11.001_bib0705","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1016\/j.vaccine.2015.05.041","article-title":"Immunogenicity and safety of the human papillomavirus vaccine in patients with autoimmune diseases: a systematic review","volume":"33","author":"Pellegrino","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.revmed.2024.11.001_bib0710","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019\u00a0update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2024.11.001_bib0715","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/art.42386","article-title":"2022\u00a0American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases","volume":"75","author":"Bass","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2024.11.001_bib0720","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.revmed.2016.01.005","article-title":"Prevention of infections in adults and adolescents with systemic lupus erythematosus: guidelines for the clinical practice based on the literature and expert opinion","volume":"37","author":"Mathian","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2024.11.001_bib0725","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3899\/jrheum.2022-1335","article-title":"Improving Human Papillomavirus-related cervical cancer screening in patients with systemic lupus erythematosus","volume":"50","author":"Goulenok","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2024.11.001_bib0730","doi-asserted-by":"crossref","first-page":"e0117620","DOI":"10.1371\/journal.pone.0117620","article-title":"Human Papillomavirus vaccine uptake among individuals with systemic inflammatory diseases","volume":"10","author":"Feldman","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.revmed.2024.11.001_bib0735","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/RHU.0000000000000866","article-title":"Lack of uptake of prophylactic human papilloma virus vaccine among women with systemic lupus erythematosus seen at a Regional Medical Center","volume":"25","author":"Dhar","year":"2019","journal-title":"J Clin Rheumatol"},{"issue":"14","key":"10.1016\/j.revmed.2024.11.001_bib0740","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.3390\/jcm11144137","article-title":"Human Papilloma virus vaccination in patients with rheumatic diseases in France: a study of vaccination coverage and drivers of vaccination","volume":"11","author":"David","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.revmed.2024.11.001_bib0745","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmi.2021.10.016","article-title":"Public opinion on a mandatory COVID-19\u00a0vaccination policy in France: a cross-sectional survey","volume":"28","author":"Gagneux-Brunon","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.revmed.2024.11.001_bib0750","unstructured":"Goulenok T, Fran\u00e7ois C, Mageau A, Hachulla E, Papo T, Sacr\u00e9 K National Survey on Patient's Knowledge and Drivers of Human Papillomavirus (HPV) Vaccination in Immune-mediated Inflammatory Diseases (IMIDs). J rheumatol.."},{"key":"10.1016\/j.revmed.2024.11.001_bib0755","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1038\/s41591-023-02600-4","article-title":"Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population","volume":"29","author":"Simms","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.revmed.2024.11.001_bib0760","first-page":"45","article-title":"Cancer screening in patients with systemic lupus erythematosus","volume":"33","author":"Bernatsky","year":"2006","journal-title":"J Rheumatol"},{"issue":"7S Suppl1","key":"10.1016\/j.revmed.2024.11.001_bib0765","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/RHU.0000000000002122","article-title":"HPV infection and prevention in patients with immune-mediated inflammatory diseases: a scoping review","volume":"30","author":"Goulenok","year":"2024","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.revmed.2024.11.001_bib0770","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2024.11.001_bib0775","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ygyno.2014.05.026","article-title":"Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: a cross-sectional study","volume":"134","author":"Haguenoer","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.revmed.2024.11.001_bib0780","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.3390\/ijerph20166613","article-title":"Effectiveness of clinic-based patient-led human papillomavirus DNA self-sampling among HIV-infected women in Uganda","volume":"20","author":"Nyabigambo","year":"2023","journal-title":"IJERPH"},{"key":"10.1016\/j.revmed.2024.11.001_bib0785","series-title":"Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices","first-page":"68","author":"Meites","year":"2019"},{"key":"10.1016\/j.revmed.2024.11.001_bib0790","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1080\/21645515.2020.1852870","article-title":"Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45\u00a0years in the United States","volume":"17","author":"Daniels","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.revmed.2024.11.001_bib0795","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2352-4642(18)30220-7","article-title":"Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study","volume":"2","author":"Silverberg","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.revmed.2024.11.001_bib0800","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24\u201345\u00a0years: a randomised, double-blind trial","volume":"373","author":"Mu\u00f1oz","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2024.11.001_bib0805","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/bjc.2011.185","article-title":"End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24\u201345\u00a0years of age","volume":"105","author":"Castellsagu\u00e9","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.revmed.2024.11.001_bib0810","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/M19-1182","article-title":"Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45\u00a0years in the United States","volume":"172","author":"Laprise","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2024.11.001_bib0815","doi-asserted-by":"crossref","first-page":"e13590","DOI":"10.1111\/ctr.13590","article-title":"Human papillomavirus infection in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Chin-Hong","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.revmed.2024.11.001_bib0820","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e1401","article-title":"Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data","volume":"344","author":"Joura","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2024.11.001_bib0825","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/vaccines10020239","article-title":"HPV vaccination after primary treatment of HPV-related disease across different organ sites: a multidisciplinary comprehensive review and meta-analysis","volume":"10","author":"Di Donato","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.revmed.2024.11.001_bib0830","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/vaccines10020288","article-title":"Effectiveness of prophylactic human papillomavirus vaccine in the prevention of recurrence in women conized for HSIL\/CIN 2-3: the VENUS study","volume":"10","author":"Casajuana-P\u00e9rez","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.revmed.2024.11.001_bib0835","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12889-020-8371-z","article-title":"Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial","volume":"20","author":"Karimi-Zarchi","year":"2020","journal-title":"BMC Public Health"},{"year":"2017","series-title":"Pr\u00e9vention des infections \u00e0 HPV: place du vaccin Gardasil 9\u00ae","key":"10.1016\/j.revmed.2024.11.001_bib0840"},{"key":"10.1016\/j.revmed.2024.11.001_bib0845","unstructured":"HPV vaccination | NCIRS. https:\/\/ncirs.org.au\/public\/hpv-vaccination. (accessed March 20, 2024)."},{"key":"10.1016\/j.revmed.2024.11.001_bib0850","unstructured":"The Green book: immunisation against infectious disease in the UK. https:\/\/assets.publishing.service.gov.uk\/media\/649032b6b32b9e000ca969a7\/HPV-green-book-chapter-18a-June-2023.pdf. (accessed March 20, 2024)."},{"key":"10.1016\/j.revmed.2024.11.001_bib0855","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/LGT.0000000000000468","article-title":"Guidelines for cervical cancer screening in immunosuppressed women without HIV infection","volume":"23","author":"Moscicki","year":"2019","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.revmed.2024.11.001_bib0430","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324012748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324012748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T12:16:59Z","timestamp":1741004219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324012748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0248866324012748"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2024.11.001","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human papillomavirus et lupus syst\u00e9mique\u00a0: une revue syst\u00e9matique","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2024.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}